Comparison between ketotifen and DSCG in bronchial challenge
- 1 May 1978
- journal article
- research article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 8 (3), 289-293
- https://doi.org/10.1111/j.1365-2222.1978.tb03226.x
Abstract
A double-blind cross-over study showed that orally taken ketotifen and inhaled DSCG have a comparable protective effect on allergen-induced bronchoconstriction. Both drugs significantly inhibit the immediate bronchial reaction after a 3 day treatment with either 1 mg ketotifen or 20 mg DSCG four times daily. Late reactions, which occurred in three out of the ten patients, were inhibited in two of the three patients by ketotifen as by DSCG.This publication has 10 references indexed in Scilit:
- ANTI‐ASTHMATIC PROPERTIES OF A NEW PERORAL DRUG (HC 20–511.)Allergy, 1977
- FURTHER STUDIES ON HE EFFECT OF ORAL DOXANTRAZOLE ON ALLERGEN-INDUCED BRONCHOSPASMAllergy, 1976
- The inhibition of allergen induced bronchospasm in man by oral BRL 10833Clinical and Experimental Allergy, 1976
- THE EFFECT OF ORAL DOXANTRAZOLE ON ALLERGEN-INDUCED BRONCHOSPASMAllergy, 1976
- Cromoglycate and other antiallergic drugs: a possible mechanism of action.BMJ, 1976
- IgE antibodies to house dust, mite, animal allergens and moulds in house dust hypersensitivityClinical and Experimental Allergy, 1976
- Allergy and parasites: the measurement of total and specific IgE levels in urban and rural communities in RhodesiaClinical and Experimental Allergy, 1976
- Inhibition of Allergen-Induced Bronchospasm in Patients with Reversible Bronchial Obstruction by a New Xanthone DerivativeRespiration, 1976
- ICI 74,917: A NEW ANTI‐ALLERGIC DRUG ADMINISTERED BY PRESSURISED AEROSOLAllergy, 1975
- DOXANTRAZOLE, AN ANTIALLERGIC AGENT ORALLY EFFECTIVE IN MANThe Lancet, 1975